Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 145

Sort by

Sort Order Select

Journal Articles

Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML)

Alessandro Leoni, Mirko Farina, Diego Bertoli, Carlotta Giupponi, Erika Borlenghi, Besjana Xhahysa, Luca Garuffo, Alessia Cavalleri, Federica Trenta, Federica Re, Silvia Mutti, Daniele Avenoso, Michele Malagola, Domenico Russo, Roberto Bresciani, Giorgio Biasiotto, Simona Bernardi

Blood (2025) 146 (Supplement 1): 7023.

https://doi.org/10.1182/blood-2025-7023

Published: 2025

Journal Articles

Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study

Alessandro Leoni, Elsa Cavagna, Enrico Morello, Giulia Benedini, Giulia Brambilla, Daniele Avenoso, Simona Bernardi, Mirko Farina, Gabriele Magliano, Vera Radici, Domenico Russo, Michele Malagola

Blood (2025) 146 (Supplement 1): 2497.

https://doi.org/10.1182/blood-2025-2497

Published: 2025

Journal Articles

Transcriptomic analysis of CD34⁺ cells in myelofibrosis highlights their role in extracellular matrix dysregulation and marrow fibrosis

Simona Bernardi, Luca Garuffo, Mirko Farina, Giulia Pozzi, Livia Micaela Pasini, Samuele Cortellazzi, Alessandro Leoni, Orsola Di Martino, Francesca Arciprete, Maria Zingariello, Marco Vitale, Domenico Russo, Cecilia Carubbi, Elena Masselli

Blood (2025) 146 (Supplement 1): 5535.

https://doi.org/10.1182/blood-2025-5535

Published: 2025

Journal Articles

Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study

Mirko Farina, Filippo Bergamelli, Daniele Avenoso, Vera Radici, Andrea Guerini, Ludovica Pegurri, Enrico Morello, Gabriele Magliano, Beatrice Battaglio, Simone Maifredi, Sofia Terlizzi, Rachele De Domenico, Silvia Zanon, Alessandro Leoni, Simona Bernardi, Stefano Maria Magrini, Michela Buglione Di Monale e Bastia, Domenico Russo, Michele Malagola

Blood (2025) 146 (Supplement 1): 4208.

https://doi.org/10.1182/blood-2025-4208

Published: 2025

Journal Articles

Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles

Besjana Xhahysa, Simona Bernardi, Mirko Farina, Ilaria Grossi, Luca Garuffo, Rosalba Ferraro, Alessandro Leoni, Alessia Cavalleri, Silvia Mutti, Federica Trenta, Federica Re, Enrico Morello, Daniele Avenoso, Piera Balzarini, Alessandro Salvi, Michele Malagola, Domenico Russo

Blood (2025) 146 (Supplement 1): 5890.

https://doi.org/10.1182/blood-2025-5890

Published: 2025

Journal Articles

Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT

Nicola Polverelli, Juan Carlos Hernández-Boluda, Francesco Onida, Carmelo Gurnari, Kavita Raj, Tomasz Czerw, Michelle Kenyon, Marie Robin, Katja Sockel, Annalisa Ruggeri, Isabel Sánchez-Ortega, Daniel A. Arber, Luca Arcaini, Fernando Barroso Duarte, Giorgia Battipaglia, Yves Chalandon, Fabio Ciceri, Nicholas C. P. Cross, Joanna Drozd-Sokolowska, Vaneuza Funke, Nico Gagelmann, Naseema Gangat, Jason Gotlib, Paola Guglielmelli, Claire Harrison, Gabriela Hobbs, Tania Jain, Joseph D. Khoury, Jean Jacques Kiladjian, Nicolaus Kröger, Luca Malcovati, Massimo Martino, Ruben Mesa, Attilio Orazi, Eric Padron, Francesca Palandri, Francesco Passamonti, Mrinal M. Patnaik, Naveen Pemmaraju, Deepti H. Radia, Andreas Reiter, Domenico Russo, Christof Scheid, Ayalew Tefferi, Alessandro M. Vannucchi, Daniel H. Wiseman, Ibrahim Yakoub-Agha, Donal P. McLornan

Blood (2025) 145 (22): 2561–2573.

https://doi.org/10.1182/blood.2024028000

Published: 2025

Includes: Supplemental data

Journal Articles

High Ferritin and C-Reactive Protein Levels Result in Poor Clinical Outcome in R/R Large B-Cell Lymphoma Patients Despite Significant Anti-CD19 CAR-T Cell In Vivo Expansion

Blood (2024) 144 (Supplement 1): 4786.

https://doi.org/10.1182/blood-2024-201399

Published: 2024

Journal Articles

Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study

Blood (2024) 144 (Supplement 1): 4797.

https://doi.org/10.1182/blood-2024-207660

Published: 2024

Journal Articles

Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis

Mirko Farina, Marco Chiarini, Sofia Terlizzi, Anna Galvagni, Simona Bernardi, Alessandro Leoni, Enrico Morello, Vera Radici, Gabriele Magliano, Lorenzo Masina, Marco Galli, Federica Re, Virginia Quaresima, Daniele Moratto, Duilio Brugnoni, Michele Malagola, Nicola Polverelli, Domenico Russo

Blood (2024) 144 (Supplement 1): 7372.

https://doi.org/10.1182/blood-2024-209545

Published: 2024

Journal Articles

Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Blood (2023) 142 (Supplement 1): 1513.

https://doi.org/10.1182/blood-2023-185045

Published: 2023

Journal Articles

Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study

Blood (2023) 142 (Supplement 1): 6786.

https://doi.org/10.1182/blood-2023-180302

Published: 2023

Journal Articles

Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema

Blood (2023) 142 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2023-180012

Published: 2023

Journal Articles

Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients

Simona Bernardi, Silvia Mutti, Alessia Cavalleri, Claudia Ielo, Mirko Farina, Federica Re, Katia Bosio, Alessandro Leoni, Cristian Bonvicini, Nicola Polverelli, Enrico Morello, Vera Radici, Massimo Breccia, Elisabetta Abruzzese, Michele Malagola, Domenico Russo

Blood (2023) 142 (Supplement 1): 3180.

https://doi.org/10.1182/blood-2023-185733

Published: 2023

Journal Articles

Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients

Eugenia Accorsi Buttini, Cristina Doran, Michele Malagola, Mohamad Mohty, Vera Radici, Mirko Farina, Marco Galli, Enrico Morello, Nicola Polverelli, Sofia Terlizzi, Simona Bernardi, Domenico Russo, Eolia Brissot

Blood (2023) 142 (Supplement 1): 3586.

https://doi.org/10.1182/blood-2023-180551

Published: 2023

Journal Articles

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

Robert Zeiser, Domenico Russo, Ron Ram, Shahrukh K Hashmi, Ronjon Chakraverty, Jan Moritz Middeke, Maurizio Musso, Sebastian Giebel, Ant Uzay, Peter Langmuir, Nada Hamad, Xuechan Li, Maanasa Gowda, Tommaso Stefanelli, Stephanie J. Lee, Takanori Teshima, Franco Locatelli

Blood (2023) 142 (Supplement 1): 654.

https://doi.org/10.1182/blood-2023-172590

Published: 2023

Journal Articles

Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration

Federica Re, Luciana Sartore, Elisa Borsani, Matteo Ferroni, Chiara Pasini, Stefano Pandini, Simona Bernardi, Katia Bosio, Silvia Mutti, Alessia Cavalleri, Alessandro Leoni, Nicola Polverelli, Enrico Morello, Mirko Farina, Vera Radici, Michele Malagola, Domenico Russo

Blood (2023) 142 (Supplement 1): 5626.

https://doi.org/10.1182/blood-2023-177940

Published: 2023

Journal Articles

3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients

Blood (2023) 142 (Supplement 1): 3165.

https://doi.org/10.1182/blood-2023-177619

Published: 2023

Journal Articles

Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients

Blood (2023) 142 (Supplement 1): 2070.

https://doi.org/10.1182/blood-2023-184455

Published: 2023

Journal Articles

Impact of Fourth Methotrexate Dose in ATG-Cyclosporine GvHD Prophylaxis in HLA-Matched Unrelated HSCT: A GITMO Study

Blood (2022) 140 (Supplement 1): 10514–10516.

https://doi.org/10.1182/blood-2022-162853

Published: 2022

Journal Articles

Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 7667–7669.

https://doi.org/10.1182/blood-2022-162472

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML)

Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study

Transcriptomic analysis of CD34⁺ cells in myelofibrosis highlights their role in extracellular matrix dysregulation and marrow fibrosis

Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study

Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles

Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT

High Ferritin and C-Reactive Protein Levels Result in Poor Clinical Outcome in R/R Large B-Cell Lymphoma Patients Despite Significant Anti-CD19 CAR-T Cell In Vivo Expansion

Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study

Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis

Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study

Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema

Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients

Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration

3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients

Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients

Impact of Fourth Methotrexate Dose in ATG-Cyclosporine GvHD Prophylaxis in HLA-Matched Unrelated HSCT: A GITMO Study

Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only